Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathologic staging of melanoma.

Dirk J Ruiter1, Alain Spatz, Joost J van den Oord

  • 1Department of Pathology, University Medical Center St Radboud, Nijmegen, The Netherland.

Seminars in Oncology
|August 10, 2002
PubMed
Summary

The AJCC updated the cutaneous melanoma staging system using global patient data. This system incorporates primary tumor features, metastasis, and sentinel lymph node micrometastasis for improved prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC).

European journal of cancer (Oxford, England : 1990)·2026
Same author

Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome.

The Journal of investigative dermatology·2025
Same author

Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5.

Journal of cutaneous pathology·2025
Same author

Frequency of naevus cells in lymph nodes of melanoma and breast cancer patients.

Pathology, research and practice·2024
Same author

Prognosis of naevoid melanomas.

Pathology, research and practice·2023
Same author

Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.

European journal of cancer (Oxford, England : 1990)·2023

Area of Science:

  • Oncology
  • Dermatology
  • Pathology

Background:

  • The American Joint Committee on Cancer (AJCC) introduced a new staging system for cutaneous melanoma.
  • This system is based on extensive clinical data from international treatment centers.
  • It integrates histopathologic features of the primary tumor and metastatic disease.

Purpose of the Study:

  • To discuss the components of the new AJCC staging system for cutaneous melanoma.
  • To highlight key prognostic factors within the updated system.
  • To review the pathological examination of sentinel lymph nodes (SLNs) in melanoma staging.

Main Methods:

  • Review of the AJCC's latest staging criteria for cutaneous melanoma.
  • Analysis of histopathologic parameters, including primary tumor characteristics and metastasis.

Related Experiment Videos

  • Evaluation of sentinel lymph node (SLN) micrometastasis detection methods.

    • Main Results:

    • Ulceration of the primary tumor remains a significant prognostic indicator, alongside tumor thickness.
    • The new system incorporates various histopathologic parameters and molecular markers.
    • Different microstaging approaches for SLNs are examined for their efficacy.

    Conclusions:

    • The updated AJCC staging system provides a comprehensive approach to cutaneous melanoma prognosis.
    • Accurate histopathologic assessment, including SLN analysis, is crucial for patient management.
    • Understanding these parameters aids in predicting melanoma behavior and guiding treatment strategies.